{"id":79216,"date":"2022-01-20T15:35:00","date_gmt":"2022-01-20T14:35:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=79216"},"modified":"2022-01-20T14:27:36","modified_gmt":"2022-01-20T13:27:36","slug":"135-million-euros-for-laboratory-startup-preomics","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/79216\/135-million-euros-for-laboratory-startup-preomics\/","title":{"rendered":"13.5 million euros for laboratory startup Preomics"},"content":{"rendered":"<div class=\"entry-content\">\n<p>Preomics was founded in 2016 by Garwin Pichler and Nils A. Kulak as a spin-out company from the laboratory of proteomics researcher Professor Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried. <a href=\"\/en\/63013\/startup-start-up-company\/\">Startup<\/a> supports pharmaceutical and clinical research with automation solutions and consumables for the homogenization, enrichment and proteomic sample preparation of biopsy, tissue, cell line and plasma samples. <strong>Garwin Pichler<\/strong>, co-founder and CEO of Preomics, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are pleased to increase our investments in R&amp;D, marketing, and sales and to have Bruker as a collaboration partner and lead investor. Bruker shares our vision of making advanced technologies for proteomic analysis available to everyone and will accelerate our growth through this funding. Our existing and future customers and partners will benefit from the investments in Preomics and the synergies in proteomics solutions to expand our product offering and global presence.&quot;<\/p><\/blockquote>\n\n\n\n<p>The second co-founder and managing director <strong>Nils A. Kulak <\/strong>says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We see a promising future for Preomics&#039; research, development, and commercialization activities, which will be accelerated by the Series B funding and Bruker as a partner. Our novel Beatbox technology is seamlessly compatible with Preomics&#039; proteomics sample preparation technologies and, in combination with the TimsTOF Pro, offers complete workflows for processing large tissue biobanks. Our goal is to develop complete, user-friendly, and automated Beatbox-based workflows for any throughput, thus providing solutions for highly efficient proteomic analysis.&quot;<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">\u201cPreomics is a leading proteomics company\u201d<\/h2>\n\n\n\n<p>The investment represents a successful exit for several early-stage investors: High-Tech Gr\u00fcnderfonds and Thinkhealth Ventures, as well as several business angels, successfully sold their Preomics shares to Bruker in a parallel secondary transaction. The US company is now the majority investor in the Munich-based company. Financial details of the secondary transactions were not disclosed.<\/p>\n\n\n\n<p><strong>Bernd Goergen<\/strong>, partner at High-Tech Gr\u00fcnderfonds, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;That our time as a seed investor in Preomics is coming to an end after just five years is a testament to the fantastic performance of both the management and the highly innovative technology. Many thanks to Garwin and Nils for allowing us to be a part of your journey. The merger with your partner Bruker Inc. now paves the way to setting gold standards in protein preparation and will thus make proteomic analysis easier and more reliable than ever.&quot;<\/p><\/blockquote>\n\n\n\n<p><strong>Frank H. Laukien<\/strong>, President and CEO of Bruker Corporation, says:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are very pleased to invest in Preomics, a leading company in sample preparation, automation, and consumables for proteomics, with this Series B financing. By acquiring a majority stake in Preomics, Bruker is expanding its proteomics vision to include Preomics&#039; unique sample preparation technologies and complete, automated, robust, and reproducible workflows for translational biomarker and biopharma proteomics research.&quot;<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Preomics, a startup based at the IZB in Martinsried, develops automation and sample preparation technologies for proteomic analyses. The American company Bruker is investing \u20ac13.5 million in the Munich-based company.<\/p>","protected":false},"author":26,"featured_media":79217,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,1863],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>13,5 Millionen Euro f\u00fcr Labor-Startup Preomics - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das amerikanische Unternehmen Bruker steigt im Rahmen einer Series-B beim M\u00fcnchner Labor-Startup Preomics mit 13,5 Millionen Euro ein.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/79216\/135-million-euros-for-laboratory-startup-preomics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"13,5 Millionen Euro f\u00fcr Labor-Startup Preomics - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das amerikanische Unternehmen Bruker steigt im Rahmen einer Series-B beim M\u00fcnchner Labor-Startup Preomics mit 13,5 Millionen Euro ein.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/79216\/135-million-euros-for-laboratory-startup-preomics\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-20T14:35:00+00:00\" \/>\n<meta name=\"author\" content=\"Simon Tischer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Tischer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/\",\"url\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/\",\"name\":\"13,5 Millionen Euro f\u00fcr Labor-Startup Preomics - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg\",\"datePublished\":\"2022-01-20T14:35:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\"},\"description\":\"Das amerikanische Unternehmen Bruker steigt im Rahmen einer Series-B beim M\u00fcnchner Labor-Startup Preomics mit 13,5 Millionen Euro ein.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg\",\"width\":2400,\"height\":1600,\"caption\":\"Die beiden Gesch\u00e4ftsf\u00fchrer von Preomics Garwin Pichler und Nils A. Kulak (v.l.).\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"13,5 Millionen Euro f\u00fcr Labor-Startup Preomics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\",\"name\":\"Simon Tischer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"caption\":\"Simon Tischer\"},\"description\":\"Von Dezember 2015 bis Juni 2023 war Simon Tischer als Redakteur f\u00fcr Munich Startup t\u00e4tig.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"13.5 million euros for laboratory startup Preomics - Munich Startup","description":"The American company Bruker is investing 13.5 million euros in a Series B investment in the Munich-based laboratory startup Preomics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/79216\/135-million-euros-for-laboratory-startup-preomics\/","og_locale":"en_US","og_type":"article","og_title":"13,5 Millionen Euro f\u00fcr Labor-Startup Preomics - Munich Startup","og_description":"Das amerikanische Unternehmen Bruker steigt im Rahmen einer Series-B beim M\u00fcnchner Labor-Startup Preomics mit 13,5 Millionen Euro ein.","og_url":"https:\/\/cms.munich-startup.net\/en\/79216\/135-million-euros-for-laboratory-startup-preomics\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2022-01-20T14:35:00+00:00","author":"Simon Tischer","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Simon Tischer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/","url":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/","name":"13.5 million euros for laboratory startup Preomics - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg","datePublished":"2022-01-20T14:35:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d"},"description":"The American company Bruker is investing 13.5 million euros in a Series B investment in the Munich-based laboratory startup Preomics.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg","width":2400,"height":1600,"caption":"Die beiden Gesch\u00e4ftsf\u00fchrer von Preomics Garwin Pichler und Nils A. Kulak (v.l.)."},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/79216\/135-millionen-euro-fuer-labor-startup-preomics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"13,5 Millionen Euro f\u00fcr Labor-Startup Preomics"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d","name":"Simon Tischer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","caption":"Simon Tischer"},"description":"From December 2015 to June 2023, Simon Tischer worked as an editor for Munich Startup.","url":"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/"}]},"og_image":[{"width":2400,"height":1600,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2022\/01\/Dr.-Garwin-Pichler-und-Dr.-Nils-A.-Kulak-beide-Geschaeftsfuehrer-PreOmics-GmbH.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1642685259:33","_edit_last":"33","_yoast_wpseo_focuskw":"Preomics","_yoast_wpseo_metadesc":"Das amerikanische Unternehmen Bruker steigt im Rahmen einer Series-B beim M\u00fcnchner Labor-Startup Preomics mit 13,5 Millionen Euro ein.","_yoast_wpseo_linkdex":"71","_thumbnail_id":"79217","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/79216"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=79216"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/79216\/revisions"}],"predecessor-version":[{"id":79226,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/79216\/revisions\/79226"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/79217"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=79216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=79216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=79216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}